| Identification | Back Directory | [Name]
Ficlatuzumab | [CAS]
1174900-84-5 | [Synonyms]
Ficlatuzumab
Ficlatuzumab (anti-HGF)
Research Grade Ficlatuzumab(DHD03701) |
| Hazard Information | Back Directory | [Uses]
Ficlatuzumab is a monoclonal antibody (McAb) targeting human hepatocyte growth factor (HGF). Ficlatuzumab blocks the activation of the HGF/c-Met signaling pathway, and inhibits c-Met receptor-mediated cancer cell proliferation, migration, and invasion[1]. | [References]
[1] Kumar D, et al. Mitigation of Tumor-Associated Fibroblast-Facilitated Head and Neck Cancer Progression With Anti-Hepatocyte Growth Factor Antibody Ficlatuzumab. JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1133-9. DOI:10.1001/jamaoto.2015.2381 |
|
| Company Name: |
Biolab Reagents
|
| Tel: |
18108604356 18108604356 |
| Website: |
www.biolabreagent.com/ |
| Company Name: |
Cell Sciences
|
| Tel: |
9785721070 |
| Website: |
www.cellsciences.com |
|